Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID Reference, 4th edition, 372 pages + the daily Top 10

Ischemic Heart Disease

Free Subscription 20.07.2020 3 Am Heart J 13 Am J Cardiol 3 Am J Med 1 Am J Public Health 1 Ann Thorac Surg 3 Arterioscler Thromb Vasc Biol 2 BMJ 1 Cardiovasc Res 4 Catheter Cardiovasc Interv 2 Circ Cardiovasc Imaging 1 Circ Cardiovasc Interv 1 Circ Cardiovasc Qual Outcomes 2 Circ Res 4 Circulation 3 Clin Cardiol 2 Dtsch Med Wochenschr 7 Eur Heart J 2 Hypertension 1 J Clin Endocrinol Metab 2 J Thorac Cardiovasc Surg 2 JAMA 6 N Engl J Med 1 PLoS Med 1 PLoS One 1 Thromb Haemost

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am Heart J

1. SILVAIN J, Cayla G, Beygui F, Range G, et al
   Blunting periprocedural myocardial necrosis: Rationale and design of the randomized ALPHEUS study.
   Am Heart J. 2020;225:27-37.
   PubMed         Abstract available
   
   
2. YAN Y, Wang X, Guo J, Li Y, et al
   Rationale and design of the RIGHT trial: A multicenter, randomized, double-blind, placebo-controlled trial of anticoagulation prolongation versus no anticoagulation after primary percutaneous coronary intervention for ST-segment elevation myocardial i
   Am Heart J. 2020;227:19-30.
   PubMed         Abstract available
   
   
3. ERHUN F, Kaplan RS, Narayanan VG, Brayton K, et al
   Are cost advantages from a modern Indian hospital transferable to the United States?
   Am Heart J. 2020;224:148-155.
   PubMed         Abstract available
   
   

   
   Am J Cardiol

4. CHANGAL K, Masroor S, Elzanaty A, Patel M, et al
   Meta-Analysis Comparing Multiple Arterial Grafts Versus Single Arterial Graft for Coronary-Artery Bypass Grafting.
   Am J Cardiol. 2020 Jun 16. pii: S0002-9149(20)30587.
   PubMed         Abstract available
   
   
5. KWOK CS, Sirker A, Nolan J, Zaman A, et al
   A National Evaluation of Emergency Cardiac Surgery After Percutaneous Coronary Intervention and Postsurgical Patient Outcomes.
   Am J Cardiol. 2020 Jun 7. pii: S0002-9149(20)30552.
   PubMed         Abstract available
   
   
6. COMPAGNONE M, Taglieri N, Celeski M, Ghetti G, et al
   Impact of Elective, Uncomplicated Target Lesion Revascularization on Cardiac Mortality After Elective Percutaneous Coronary Intervention of Unprotected Left Main Coronary Artery Disease.
   Am J Cardiol. 2020;128:94-100.
   PubMed         Abstract available
   
   
7. VOLIS I, Saliba W, Jaffe R, Eitan A, et al
   Effect of Cerebrovascular and/or Peripheral Artery Disease With or Without Attainment of Lipid Goals on Long-Term Outcomes in Patients With Coronary Artery Disease.
   Am J Cardiol. 2020;128:28-34.
   PubMed         Abstract available
   
   
8. FABIJANIC D, Luksic B, Ljubkovic M
   Reader's Comment on Meta-analysis of C-Reactive Protein and Risk of Angina Pectoris.
   Am J Cardiol. 2020;128:160.
   PubMed        
   
   
9. AGGARWAL S, Aggarwal G, Loomba RS
   Sleep Duration and Cardiovascular Disease Prevalence - The Debate Continues.
   Am J Cardiol. 2020;128:159.
   PubMed        
   
   
10. KAJY M, Laktineh A, Blank N, Tayal R, et al
    Deploying Mechanical Circulatory Support Via the Axillary Artery in Cardiogenic Shock and High-Risk Percutaneous Coronary Intervention.
    Am J Cardiol. 2020;128:127-133.
    PubMed         Abstract available
    
    
11. KOBO O, Mohamed MO, Farmer AD, Alraies CM, et al
    Outcomes of Percutaneous Coronary Intervention in Patients With Crohn's Disease and Ulcerative Colitis (from a Nationwide Cohort).
    Am J Cardiol. 2020 Jun 17. pii: S0002-9149(20)30588.
    PubMed         Abstract available
    
    
12. NAIROOZ R, Parzynski CS, Curtis JP, Mohsen A, et al
    Contemporary Trends, Predictors and Outcomes of Perforation During Percutaneous Coronary Intervention (From the NCDR Cath PCI Registry).
    Am J Cardiol. 2020 Jun 17. pii: S0002-9149(20)30589.
    PubMed         Abstract available
    
    
13. KADAVATH S, Mohan J, Ashraf S, Kassier A, et al
    Cardiac Catheterization Laboratory Volume Changes During COVID-19-Findings from a Cardiovascular Fellows Consortium.
    Am J Cardiol. 2020 Jun 11. pii: S0002-9149(20)30565.
    PubMed        
    
    
14. BURGESS SN, Juergens CP, Nguyen TL, Leung M, et al
    Comparison of Late Cardiac Death and Myocardial Infarction Rates in Women Vs Men With ST-Elevation Myocardial Infarction.
    Am J Cardiol. 2020;128:120-126.
    PubMed         Abstract available
    
    
15. ELGENDY IY, Gad M, Mintz GS
    Meta-Analysis of Intravascular Ultrasound-Guided Drug-Eluting Stent Implantation for Left Main Coronary Disease.
    Am J Cardiol. 2020;128:92-93.
    PubMed        
    
    
16. BODEN WE, Hartigan PM, Mancini J, Teo KK, et al
    Risk Prediction Tool for Assessing the Probability of Death or Myocardial Infarction in Patients With Stable Coronary Artery Disease.
    Am J Cardiol. 2020 Jun 8. pii: S0002-9149(20)30557.
    PubMed         Abstract available
    
    

    
    Am J Med

17. MASSOOMI MR, Anderson RD, Ahmed MM, Dasa O, et al
    Cardiovascular Considerations for the Internist and Hospitalist in the COVID-19 Era.
    Am J Med. 2020 Jul 9. pii: S0002-9343(20)30550.
    PubMed         Abstract available
    
    
18. PATEL S, Minish JM, Keeley EC
    Acromegaly-Induced Cardiomyopathy Masquerading as an Acute Coronary Syndrome.
    Am J Med. 2020 Jul 9. pii: S0002-9343(20)30548.
    PubMed        
    
    
19. KRITTANAWONG C, Narasimhan B, Wang Z, Virk HUH, et al
    Association Between Egg Consumption and Risk of Cardiovascular Outcomes: A Systematic Review and Meta-Analysis.
    Am J Med. 2020 Jul 9. pii: S0002-9343(20)30549.
    PubMed         Abstract available
    
    

    
    Am J Public Health

20. GUADAMUZ JS, Durazo-Arvizu RA, Daviglus ML, Perreira KM, et al
    Immigration Status and Disparities in the Treatment of Cardiovascular Disease Risk Factors in the Hispanic Community Health Study/Study of Latinos (Visit 2, 2014-2017).
    Am J Public Health. 2020 Jul 16:e1-e8. doi: 10.2105/AJPH.2020.305745.
    PubMed         Abstract available
    
    

    
    Ann Thorac Surg

21. MATTHEWS CR, Millward JB, Faiza Z, Namburi N, et al
    Outcomes of surgical coronary revascularization performed pre-solid abdominal organ transplant.
    Ann Thorac Surg. 2020 Jul 8. pii: S0003-4975(20)31109.
    PubMed         Abstract available
    
    

    
    Arterioscler Thromb Vasc Biol

22. NARULA N, Olin JW, Narula N
    Pathologic Disparities Between Peripheral Artery Disease and Coronary Artery Disease.
    Arterioscler Thromb Vasc Biol. 2020 Jul 16:ATVBAHA119312864.
    PubMed         Abstract available
    
    
23. OHURA-KAJITANI S, Shiroto T, Godo S, Ikumi Y, et al
    Marked Impairment of Endothelium-Dependent Digital Vasodilatations in Patients With Microvascular Angina: Evidence for Systemic Small Artery Disease.
    Arterioscler Thromb Vasc Biol. 2020;40:1400-1412.
    PubMed         Abstract available
    
    
24. CHEN W, Werner F, Illerhaus A, Knopp T, et al
    Stabilization of Perivascular Mast Cells by Endothelial CNP (C-Type Natriuretic Peptide).
    Arterioscler Thromb Vasc Biol. 2020;40:682-696.
    PubMed         Abstract available
    
    

    
    BMJ

25. GRIFFIN S
    Covid-19: Data show 5000 fewer hospital admissions for acute coronary syndrome during pandemic.
    BMJ. 2020;370:m2852.
    PubMed        
    
    
26. CAI X, Zhang Y, Li M, Wu JH, et al
    Association between prediabetes and risk of all cause mortality and cardiovascular disease: updated meta-analysis.
    BMJ. 2020;370:m2297.
    PubMed         Abstract available
    
    

    
    Cardiovasc Res

27. TAO Z, Loo S, Su L, Tan S, et al
    Angiopoietin-1 enhanced myocyte mitosis, engraftment, and the reparability of hiPSC-CMs for treatment of myocardial infarction.
    Cardiovasc Res. 2020 Jul 14. pii: 5871500. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Catheter Cardiovasc Interv

28. LI X, Kan J, She L, Shrestha R, et al
    Optical coherence tomography predictors of target vessel myocardial infarction after provisional stenting in patients with coronary bifurcation disease.
    Catheter Cardiovasc Interv. 2020 Jul 13. doi: 10.1002/ccd.28980.
    PubMed         Abstract available
    
    
29. ONG E, Castro-Dominguez Y, Brennan J, Oen-Hsiao J, et al
    COVID-19 complicated by ST-segment elevation myocardial infarction in a 29-year-old patient.
    Catheter Cardiovasc Interv. 2020 Jul 16. doi: 10.1002/ccd.29102.
    PubMed         Abstract available
    
    
30. HANSON ID, Tagami T, Mando R, Kara Balla A, et al
    SCAI shock classification in acute myocardial infarction: Insights from the National Cardiogenic Shock Initiative.
    Catheter Cardiovasc Interv. 2020 Jul 16. doi: 10.1002/ccd.29139.
    PubMed         Abstract available
    
    
31. POPOVIC B, Varlot J, Metzdorf PA, Jeulin H, et al
    Changes in characteristics and management among patients with ST-elevation myocardial infarction due to COVID-19 infection.
    Catheter Cardiovasc Interv. 2020 Jul 15. doi: 10.1002/ccd.29114.
    PubMed         Abstract available
    
    

    
    Circ Cardiovasc Imaging

32. RAI A, Sharafat J, Muhammad S, Siddique M, et al
    Letter by Rai et al Regarding Article, "Left Atrial End-Diastolic Volume Index as a Predictor of Cardiovascular Outcomes".
    Circ Cardiovasc Imaging. 2020;13:e011063.
    PubMed        
    
    
33. JENSEN JC, Dardari ZA, Blaha MJ, White S, et al
    Association of Body Mass Index With Coronary Artery Calcium and Subsequent Cardiovascular Mortality: The Coronary Artery Calcium Consortium.
    Circ Cardiovasc Imaging. 2020;13:e009495.
    PubMed         Abstract available
    
    

    
    Circ Cardiovasc Interv

34. ABADIE BQ, Cannon CP, Cavender MA
    Novel Oral Anticoagulants Following Percutaneous Coronary Intervention.
    Circ Cardiovasc Interv. 2020;13:e008465.
    PubMed         Abstract available
    
    

    
    Circ Cardiovasc Qual Outcomes

35. SIMS M, Kershaw KN, Breathett K, Jackson EA, et al
    Importance of Housing and Cardiovascular Health and Well-Being: A Scientific Statement From the American Heart Association.
    Circ Cardiovasc Qual Outcomes. 2020 Jul 15:HCQ0000000000000089.
    PubMed         Abstract available
    
    

    
    Circ Res

36. 
    Correction to: Obesity Phenotypes, Diabetes, and Cardiovascular Diseases.
    Circ Res. 2020;127:e107.
    PubMed        
    
    
37. GOODCHILD TT, Lefer DJ
    Obstructive Sleep Apnea: The Not-So-Silent Killer.
    Circ Res. 2020;126:229-231.
    PubMed        
    
    

    
    Circulation

38. MESSERLI FH, Siontis GCM, Raber L
    Letter by Messerli et al Regarding Article, "Incidence, Trends, and Outcomes of Type 2 Myocardial Infarction in a Community Cohort".
    Circulation. 2020;142:e27-e28.
    PubMed        
    
    
39. RAPHAEL CE, Roger VL, Sandoval Y, Singh M, et al
    Response by Raphael et al to the Letters Regarding Article, "Incidence, Trends, and Outcomes of Type 2 Myocardial Infarction in a Community Cohort".
    Circulation. 2020;142:e29-e30.
    PubMed        
    
    
40. SCHOEPFER H, Nestelberger T, Mueller C
    Letter by Schoepfer et al Regarding Article, "Incidence, Trends, and Outcomes of Type 2 Myocardial Infarction in a Community Cohort".
    Circulation. 2020;142:e25-e26.
    PubMed        
    
    
41. 
    Correction to: Population Trends in Rates of Percutaneous Coronary Revascularization for Acute Coronary Syndromes Associated With the COVID-19 Outbreak.
    Circulation. 2020;142:e32.
    PubMed        
    
    

    
    Clin Cardiol

42. MIKI K, Imamura T
    Association between cardiovascular manifestation and COVID-19.
    Clin Cardiol. 2020 Jul 15. doi: 10.1002/clc.23423.
    PubMed        
    
    
43. CHEN Q, Xu L, Zhu W, Ge J, et al
    Cardiovascular manifestations in severe and critical patients with COVID-19.
    Clin Cardiol. 2020 Jul 15. doi: 10.1002/clc.23422.
    PubMed        
    
    
44. CHOI Y, Yang Y, Hwang BH, Lee EY, et al
    Practical cardiovascular risk calculator for asymptomatic patients with type 2 diabetes mellitus: PRECISE-DM risk score.
    Clin Cardiol. 2020 Jul 13. doi: 10.1002/clc.23405.
    PubMed         Abstract available
    
    

    
    Dtsch Med Wochenschr

45. DARIUS H
    [Antithrombotic Therapy in Patients with Acute Coronary Syndrome and Atrial Fibrillation].
    Dtsch Med Wochenschr. 2020;145:978-986.
    PubMed         Abstract available
    
    
46. MARX N
    [Antithrombotic therapy in cardiovascular diseases].
    Dtsch Med Wochenschr. 2020;145:947.
    PubMed        
    
    

    
    Eur Heart J

47. WINDECKER S, Neumann FJ, Juni P, Sousa-Uva M, et al
    Considerations for the choice between coronary artery bypass grafting and percutaneous coronary intervention as revascularization strategies in major categories of patients with stable multivessel coronary artery disease: an accompanying article of th
    Eur Heart J. 2018 Aug 25. pii: 5077827. doi: 10.1093.
    PubMed        
    
    
48. KNUUTI J, Wijns W, Funck-Brentano C
    Anti-ischaemic medication must be adapted to each patient's characteristics and preferences in patients with chronic coronary syndromes.
    Eur Heart J. 2020;41:480-481.
    PubMed        
    
    
49. SENGUPTA PP, Shrestha S, Zeb I
    Solving coronary risk: time to feed machines some calcium (score) supplements.
    Eur Heart J. 2020;41:368-370.
    PubMed        
    
    
50. KALLISTRATOS MS, Poulimenos LE, Manolis AJ
    Beta blockers, calcium channel blockers, and long-acting nitrates for patients with stable angina and low blood pressure levels: should this recommendation be reconsidered?
    Eur Heart J. 2020;41:479.
    PubMed        
    
    
51. POSS AM, Holland WL, Summers SA
    Risky lipids: refining the ceramide score that measures cardiovascular health.
    Eur Heart J. 2020;41:381-382.
    PubMed        
    
    
52. DUDEK D, Dziewierz A, Stone G, Wijns W, et al
    The year in cardiology 2018: coronary interventions.
    Eur Heart J. 2019 Jan 2. pii: 5265297. doi: 10.1093.
    PubMed        
    
    
53. ZIMMERMANN FM, Omerovic E, Fournier S, Kelbaek H, et al
    Fractional flow reserve-guided percutaneous coronary intervention vs. medical therapy for patients with stable coronary lesions: meta-analysis of individual patient data.
    Eur Heart J. 2018 Dec 28. pii: 5265290. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Hypertension

54. RETHY L, Shah NS, Paparello JJ, Lloyd-Jones DM, et al
    Trends in Hypertension-Related Cardiovascular Mortality in the United States, 2000 to 2018.
    Hypertension. 2020 Jul 13:HYPERTENSIONAHA12015153.
    PubMed        
    
    
55. BUGIARDINI R, Yoon J, Kedev S, Stankovic G, et al
    Prior Beta-Blocker Therapy for Hypertension and Sex-Based Differences in Heart Failure Among Patients With Incident Coronary Heart Disease.
    Hypertension. 2020 Jul 13:HYPERTENSIONAHA12015323.
    PubMed         Abstract available
    
    

    
    J Clin Endocrinol Metab

56. COSMAN F, Peterson LR, Towler DA, Mitlak B, et al
    Cardiovascular Safety of Abaloparatide in Postmenopausal Women with Osteoporosis: Analysis from the ACTIVE Phase 3 Trial.
    J Clin Endocrinol Metab. 2020 Jul 13. pii: 5870711. doi: 10.1210.
    PubMed         Abstract available
    
    

    
    J Thorac Cardiovasc Surg

57. ROCHA RV, Tam DY, Fremes SE
    Commentary: Minimally invasive direct coronary artery bypass for isolated left anterior descending lesions: A welcomed innovation.
    J Thorac Cardiovasc Surg. 2020 Jun 5. pii: S0022-5223(20)31310.
    PubMed        
    
    
58. PATEL NC, Hemli JM, Seetharam K, Singh VP, et al
    Minimally invasive coronary bypass versus percutaneous coronary intervention for isolated complex stenosis of the left anterior descending coronary artery.
    J Thorac Cardiovasc Surg. 2020 May 29. pii: S0022-5223(20)31256.
    PubMed         Abstract available
    
    

    
    JAMA

59. GAUDINO M, Benedetto U, Fremes S, Ballman K, et al
    Association of Radial Artery Graft vs Saphenous Vein Graft With Long-term Cardiovascular Outcomes Among Patients Undergoing Coronary Artery Bypass Grafting: A Systematic Review and Meta-analysis.
    JAMA. 2020;324:179-187.
    PubMed         Abstract available
    
    
60. NISSEN SE, Bakaeen FG
    Coronary Revascularization Strategies: Making Sense of Sparse, Limited-Quality Data.
    JAMA. 2020;324:154-156.
    PubMed        
    
    

    
    N Engl J Med

61. LOZANO I, Rondan J, Vegas JM
    PCI or CABG for Left Main Coronary Artery Disease.
    N Engl J Med. 2020;383:290-291.
    PubMed        
    
    
62. TAGGART DP, Gaudino M
    PCI or CABG for Left Main Coronary Artery Disease.
    N Engl J Med. 2020;383:290.
    PubMed        
    
    
63. LOPEZ-AYALA P, Koechlin L, Mueller C
    PCI or CABG for Left Main Coronary Artery Disease.
    N Engl J Med. 2020;383:291.
    PubMed        
    
    
64. KAPOOR S, Mulukutla S
    PCI or CABG for Left Main Coronary Artery Disease.
    N Engl J Med. 2020;383:291-292.
    PubMed        
    
    
65. BAKAEEN FG, Svennson LG
    PCI or CABG for Left Main Coronary Artery Disease.
    N Engl J Med. 2020;383:292.
    PubMed        
    
    
66. STONE GW, Serruys PW, Sabik JF
    PCI or CABG for Left Main Coronary Artery Disease. Reply.
    N Engl J Med. 2020;383:292-294.
    PubMed        
    
    

    
    PLoS Med

67. NIKOLAKOPOULOU A, Higgins JPT, Papakonstantinou T, Chaimani A, et al
    CINeMA: An approach for assessing confidence in the results of a network meta-analysis.
    PLoS Med. 2020;17:e1003082.
    PubMed         Abstract available
    
    

    
    PLoS One

68. CHO JH, Kwon HM, Park SE, Jung JH, et al
    Protective effect of smoking cessation on subsequent myocardial infarction and ischemic stroke independent of weight gain: A nationwide cohort study.
    PLoS One. 2020;15:e0235276.
    PubMed         Abstract available
    
    

    
    Thromb Haemost

69. LIU Z, Tian R, Wang Y, Chen Q, et al
    Platelet Inhibition with Ticagrelor versus Clopidogrel in Diabetic Patients after Percutaneous Coronary Intervention for Chronic Coronary Syndromes.
    Thromb Haemost. 2020 Jul 15. doi: 10.1055/s-0040-1713375.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: